| Rapid proliferation of tumors depends on the generation of neovascularization.Neonatal blood vessels can provide sufficient oxygen and nutrition for the rapid proliferation of tumors and can take metabolites to provide a good growth microenvironment for the tumor.Currently available anti-vascular drugs are sorafenib,sunitinib and so on,although these drugs in the clinical to obtain a certain therapeutic effect,but the resistance and side effects of the production limit their clinical application,therefore,The urgent need to develop a new type of highly effective tyrosine kinase inhibitors,effectively hinder tumor angiogenesis.This study was to investigate the antitumor mechanisms of ZD-21,XCF-37b and ZJQ-24,which have been screened for anti-vasoactive compounds.ZD-21 has a certain anti-angiogenic activity,so we explore the anti-angiogenesis mechanism of ZD-21.We found that 2.5μM of ZD-21 can inhibit endothelial cell tubule formation and cell migration.20μM of ZD-21 treated HUVEC cells 2h,can inhibit the phosphorylation of VEGFR2,it also can inhibiting the downstream of the VEGFR2 signal pathway,such as p-Erk,p-FAK expression activation.Detection of ZD-21 cytotoxicity on tumor cells found that ZD-21 was more sensitive to HepG2 cells with an IC50 of 5.042 ± 0.776 μM.5μM ZD-21 treatment HepG2 cells 48h,the cell emerge G1 arrest,cell apoptosis rate is 40%.The apoptotic protein PARP and Caspase-3 were cut after treatment with 5μM ZD-21 for 48 h,and is concentration dependent.Previous studies have shown that XCF-37b has a good anti-angiogenic activity in vitro,in order to explore its in vivo anti-angiogenic activity.We used the matrix glue model to study the activity of XCF-37b to inhibit the subcutaneous capillary angiogenesis in mice.It was found that the matrix of containing 20,40,60 mg/kg XCF-37b could not see red blood cells,shows XCF-37b can inhibit the growth of mouse capillaries.The expression of HIF-la and VEGF in the cells treated with 10μM XCF-37b for 24h was significantly lower than that of the control group(P<0.05).The levels of HIF-1α and VEGF in the cells were significantly lower than those in the control group.The expression of matrix metalloproteinases(MMPs)in the process of tumor metastasis and angiogenesis was inhibited by 10μM XCF-37b treatment.The expression of MMP-9 in HT-29 cells was decreased secreted MMPs activity,10μM XCF-3 7b can reduce HT-29 cells secreted MMPs activity,and a certain concentration-dependent.Because of the good anti-angiogenesis activity of XCF-37b in vitro,we used HT-29 cells to construct mouse xenograft tumor model to detect the anti-angiogenic and anti-tumor activity in vivo,and the mouse were treated with 20mg/kg,40mg/Kg,60mg/kg consecutive administration for 7 days,we found that 60mg/kg of XCF-37b has a certain ability to inhibit tumor growth,tumor inhibition rate is 50%.The positive rate of CD-31 was inhibited by 64.9%in the 60mg/kg XCF-37b group,and the positive rate of Ki-67 was inhibited 57.3%,and the apoptosis rate is 85%.This suggests that compound XCF-37b can inhibit tumor growth by reducing tumor angiogenesis,inhibiting tumor cell proliferation,and inducing cell apoptosis.The results showed that ZJQ-24 could inhibit the activity of PI3K/AKT/mTOR signaling pathway in HepG2 cells.The results showed that ZJQ-24 could inhibit the activation of PI3K/AKT/mTOR signaling pathway in HepG2 cells.In this study,we used HepG2 cells to construct the model of xenografts in mice.The rats were treated with 20mg/kg,40mg/kg and 60mg/kg for 14 days.The results showed that 40mg/kg and 60mg/kg of ZJQ-24 can inhibit the growth of tumor in mice,tumor inhibition rate is 72.6%.Immunohistochemical study showed that the cell proliferation of the two groups of tumor cells Ki-67,mRNA translation-related protein p-4EBP1 and p-mTOR,p-AKT,p-S6,Rictor,Raptor and other mTOR signal pathway protein factor The expression also has a significant downgrade phenomenon.In conclusion,The compound ZD-21 had a certain inhibitory effect on the proliferation,migration and microtubule formation of HUVEC cells.The compound XCF-37b had good in vitro and in vivo anti-angiogenic activity in vitro.Compound ZJQ-24 had some inhibitory effects on tumor growth. |